Clinical trial
Duloxetine Versus Placebo for Fibromyalgia
NCT00489073 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00489073 |
|---|---|
| Title | Duloxetine Versus Placebo for Fibromyalgia |
| Official title | Duloxetine Versus Placebo in the Treatment of Fibromyalgia Patients With or Without Major Depressive Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | duloxetine, placebo |
| Enrollment | 345 |
| Start date | Nov 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Jun 21, 2007 |
| Last update posted | Jun 21, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: